Received: 21 May 2021
Accepted: 7 February 2022
First Online: 12 May 2022
: Samples and patient data were collected in compliance with the Declaration of Helsinki ICH-GCP, the Declaration of Taipei regarding Health Databases and Biobanks, and with local and European regulations for collection and handling of patient data. Since the study concerned retrospectively collected anonymized patient data and bacterial isolates, informed consent at the individual patient level was not required for this study. In addition, the Spanish and UK isolates were collected in accordance with their local ethics guidelines and described in prior studies [CitationRef removed–CitationRef removed]. In the Netherlands, use and analysis of bacterial isolates with anonymized patient data does not require approval from Institutional Review Boards/Ethics Committees [ExternalRef removed].Experimental protocols did not need approval by a named institutional and/or licensing committee because analysis of bacterial strains was not subject to approval.Informed consent was not required by local laws because only bacterial strains were used.
: Not applicable.
: The authors have no competing interests to declare.